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Background
Nonsteroidal anti-inflammatory drugs (NSAIDs) are one
of the most frequently used drug groups worldwide, for
their significant properties analgesic and anti-inflamma-
tory. Induce a variety of adverse reactions, both type A
(related to the effects of the drug) and type B (related to
individual response). Although the mechanisms underly-
ing the adverse effects remain unclear, inhibition of
cyclooxygenase (COX) seems to be the most accepted
explanation. For their significant analgesic, antipyretic
and anti-inflammatory, constitute an essential medicine
for the treatment of several diseases, making it impera-
tive to find a safe alternative in patients who report a
hypersensitivity reaction to AINE.
Objective
To evaluate the safety of meloxicam as analgesic and
anti-inflammatory alternative for patients who have
experienced a hypersensitivity reaction to a NSAID.
Methods
We retrospectively evaluated patients who had reported
an adverse reaction to several drugs of the NSAID
group and had been subjected to a challenge with
Meloxicam, between 2010-2013, in our allergy service in
Medellin, Colombia.
Results
A total of fifty-seven patients reported hypersensitivity
reactions to two or more NSAIDs, nineteen patients
reported an anaphylactic reactions. All were challenged
with meloxicam, thirty-six patients with incremental
doses of 1.5, 3, 4.5 and 6 mg for a total dose of 15 mg,
seventeen patients with a total dose of 7.5 mg, one
patient to 10mg and one patient 5 mg for their age.
Fifty-five patients had a negative test challenge, two
patients (3.5%) with a positive challenge, both with skin
symptoms (hives and angioedema).
Conclusion
Meloxicam is an anti-inflammatory analgesic and safe
alternative for patients who have experienced a hyper-
sensitivity reaction to 2 or more NSAIDs.
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